Oragenics, Inc.
OGEN
$0.50
-$0.01-2.27%
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 3.42M | 2.70M | 2.39M | 3.39M | 3.34M |
| Gross Profit | -3.42M | -2.70M | -2.39M | -3.39M | -3.34M |
| SG&A Expenses | 7.05M | 6.90M | 6.97M | 6.83M | 6.20M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.47M | 9.59M | 9.36M | 10.22M | 9.53M |
| Operating Income | -10.47M | -9.59M | -9.36M | -10.22M | -9.53M |
| Income Before Tax | -10.29M | -9.99M | -9.98M | -10.90M | -10.30M |
| Income Tax Expenses | -205.90K | -159.50K | -136.90K | -- | -- |
| Earnings from Continuing Operations | -10.08 | -9.83 | -9.84 | -10.90 | -10.30 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -10.08M | -9.83M | -9.84M | -10.90M | -10.30M |
| EBIT | -10.47M | -9.59M | -9.36M | -10.22M | -9.53M |
| EBITDA | -- | -- | -- | -3.35M | -5.78M |
| EPS Basic | -3.59 | -6.12 | -9.26 | -13.72 | -23.08 |
| Normalized Basic EPS | -2.27 | -3.85 | -5.81 | -8.58 | -14.42 |
| EPS Diluted | -3.59 | -6.12 | -9.26 | -13.72 | -23.08 |
| Normalized Diluted EPS | -2.27 | -3.85 | -5.81 | -8.58 | -14.42 |
| Average Basic Shares Outstanding | 14.52M | 10.83M | 7.13M | 3.57M | 2.23M |
| Average Diluted Shares Outstanding | 14.52M | 10.83M | 7.13M | 3.57M | 2.23M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |